Literature DB >> 16965168

Doppler optical coherence tomography to monitor the effect of photodynamic therapy on tissue morphology and perfusion.

Maurice C G Aalders1, Martijn Triesscheijn, Marjan Ruevekamp, Martijn de Bruin, Paul Baas, Dirk J Faber, Fiona A Stewart.   

Abstract

We investigated the feasibility of using optical coherence tomography (OCT) for noninvasive real-time visualization of the vascular effects of photodynamic therapy (PDT) in normal and tumor tissue in mice. Perfusion control measurements were initially performed after administrating vaso-active drugs or clamping of the subcutaneous tumors. Subsequent measurements were made on tumor-bearing mice before and after PDT using the photosensitizer meta-tetrahydroxyphenylchlorin (mTHPC). Tumors were illuminated using either a short drug light interval (D-L, 3 h), when mTHPC is primarily located in the tumor vasculature or a long D-L interval (48 h), when the drug is distributed throughout the whole tumor. OCT enabled visualization of the different layers of tumor, and overlying skin with a maximal penetration of < or =0.5-1 mm. PDT with a short D-L interval resulted in a significant decrease of perfusion in the tumor periphery, to 20% of pre-treatment values at 160 min, whereas perfusion in the skin initially increased by 10% (at 25 min) and subsequently decreased to 60% of pre-treatment values (at 200 min). PDT with a long D-L interval did not induce significant changes in perfusion. The concept of using noninvasive OCT measurements for monitoring early, treatment-related changes in morphology and perfusion may have applications in evaluating effects of anti-angiogenic or antivascular (cancer) therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965168     DOI: 10.1117/1.2337302

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  8 in total

Review 1.  Optical Imaging, Photodynamic Therapy and Optically Triggered Combination Treatments.

Authors:  Srivalleesha Mallidi; Bryan Q Spring; Tayyaba Hasan
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

2.  Functional optical imaging at the microscopic level.

Authors:  Beatriz Y Salazar Vázquez; Ciel Makena Hightower; Francesca Sapuppo; Daniel M Tartakovsky; Marcos Intaglietta
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

3.  Three-dimensional imaging of normal skin and nonmelanoma skin cancer with cellular resolution using Gabor domain optical coherence microscopy.

Authors:  Kye-Sung Lee; Huimin Zhao; Sherrif F Ibrahim; Natthani Meemon; Laura Khoudeir; Jannick P Rolland
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

4.  Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.

Authors:  Julie Garrier; Aude Bressenot; Susanna Gräfe; Sophie Marchal; Soumya Mitra; Thomas H Foster; François Guillemin; Lina Bezdetnaya
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-23       Impact factor: 7.038

5.  Statistical properties of phase-decorrelation in phase-resolved Doppler optical coherence tomography.

Authors:  Benjamin J Vakoc; Guillermo J Tearney; Brett E Bouma
Journal:  IEEE Trans Med Imaging       Date:  2009-01-19       Impact factor: 10.048

6.  Clinical application of optical coherence tomography for the imaging of non-melanocytic cutaneous tumors: a pilot multi-modal study.

Authors:  Ana-Maria Forsea; Elfrieda Mihaela Carstea; Luminita Ghervase; Calin Giurcaneanu; Gabriela Pavelescu
Journal:  J Med Life       Date:  2010 Oct-Dec

7.  Biphasic oxidation of oxy-hemoglobin in bloodstains.

Authors:  Rolf H Bremmer; Daniel M de Bruin; Maarten de Joode; Wybren Jan Buma; Ton G van Leeuwen; Maurice C G Aalders
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

8.  Diagnosis of oral precancer with optical coherence tomography.

Authors:  Cheng-Kuang Lee; Ting-Ta Chi; Chiung-Ting Wu; Meng-Tsan Tsai; Chun-Pin Chiang; Chih-Chung C C Yang
Journal:  Biomed Opt Express       Date:  2012-06-18       Impact factor: 3.732

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.